Retrospective Study
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Sep 24, 2016; 6(3): 594-598
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.594
Underutilization of palliative care services in the liver transplant population
Priya Kathpalia, Alexander Smith, Jennifer C Lai
Priya Kathpalia, Jennifer C Lai, Division of Gastroenterology and Hepatology, UCSF, San Francisco, CA 94143, United States
Alexander Smith, Division of Geriatrics, UCSF, San Francisco, CA 94143, United States
Author contributions: All authors contributed to the manuscript.
Institutional review board statement: This study was reviewed and approved by the UCSF Institutional Review Board.
Informed consent statement: This study was reviewed and approved by the UCSF Institutional Review Board.
Conflict-of-interest statement: There are no disclosures or conflicts-of-interest involving any of the study authors.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jennifer C Lai, MD, MBA, Division of Gastroenterology and Hepatology, UCSF, 513 Parnassus Avenue, UCSF Box 0538, San Francisco, CA 94143, United States. jennifer.lai@ucsf.edu
Telephone: +1-415-4766422 Fax: +1-415-4760659
Received: March 22, 2016
Peer-review started: March 23, 2016
First decision: May 13, 2016
Revised: June 28, 2016
Accepted: July 14, 2016
Article in press: July 18, 2016
Published online: September 24, 2016
Abstract
AIM

To evaluate use of palliative care services in patients with end-stage liver disease who do not have access to liver transplant.

METHODS

Evaluated were end-stage liver disease patients who were removed from the liver transplant wait-list or died prior to transplant at a single transplant center over a 2-year period. Those who were removed due to noncompliance or ultimately transplanted elsewhere were excluded from this study. Patient characteristics associated with palliative care consultation were assessed using logistic regression analysis.

RESULTS

Six hundred and eighty-three patients were listed for liver transplant in 2013-2014 with 107 (16%) dying (n = 62) or removed for clinical decompensation prior to liver transplant (n = 45): Median age was 58 years, and the majority were male (66%), Caucasian (53%), had Child C cirrhosis (61%) or hepatocellular carcinoma (52%). The palliative care team was consulted in only 18 of the 107 patients (17%) who died or were removed, 89% of which occurred as inpatients. Half of these consultations occurred within 72 h of death. In univariable analysis, patients of younger age, white race, and higher end-stage liver disease scores at time of listing and delisting were more likely to receive palliative care services. Only younger age [Odds ratio (OR) = 0.92; P = 0.02] and Caucasian race (OR = 4.90; P = 0.02) were still associated with integration of palliative care services through multivariable analysis.

CONCLUSION

Palliative care services are grossly underutilized in older, non-white patients with cirrhosis on the liver transplant wait-list. We encourage early integration of these services into clinical decision-making in the transplant population, with further studies aimed at understanding barriers to consultation.

Keywords: Cirrhosis, Hospice, End of life, Symptom management, Palliative care

Core tip: Without liver transplant, patients with cirrhosis have 50% mortality at 5 years; these patients represent a population that would benefit from palliative care services. Palliative care services are grossly underutilized in older, non-white patients with cirrhosis on the liver transplant wait-list. We encourage early integration of these services into clinical decision-making in the transplant population, with further studies aimed at understanding barriers to consultation.